Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Rani Therapeutics Holdings quarterly accounts receivable is not available.RANI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RANI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
RANI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Rani Therapeutics Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $71.15 M(-12.0%) |
| Dec 2022 | - | $80.84 M(+1.3%) |
| Sept 2022 | - | $79.81 M(-18.6%) |
| June 2022 | - | $98.07 M(-8.6%) |
| Mar 2022 | - | $107.34 M(-0.7%) |
| Dec 2021 | - | $108.10 M(+101.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $53.64 M(-11.2%) |
| June 2021 | - | $60.44 M(+7.6%) |
| Mar 2021 | - | $56.17 M(-16.5%) |
| Dec 2020 | - | $67.25 M(+37.7%) |
| Sept 2020 | - | $48.83 M(-1.9%) |
| June 2020 | - | $49.79 M |
FAQ
- What is the all time high quarterly accounts receivable for Rani Therapeutics Holdings?
What is the all time high quarterly accounts receivable for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly accounts receivable is $108.10 M